Vivek Thanki
ΒιΆΉΘλΏΪ
Filters
Bank of America β¬3 billion senior notes offering
The investment-grade debt offering consists of two tranches
Telemos Capital investment partnership with Helios Global Group
We are advising Telemos CapitalΒ on the transaction
Royalty Pharma $1.5 billion senior notes offering
We advised Royalty Pharma on its investment-grade notes offering
Barratt Developments Β£2.52 billion all-share offer for Redrow
We are advising UBS as financial adviser and sponsor to Barratt Developments on the transaction
Haleon $3.1 billion secondary offering
The shares are listed on the NYSE
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
NewMed Energy proposed combination with Capricorn Energy
We are advising NewMed on the transaction
Immunocore $250 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Vaccitech $75 million at-the-market offering
The ADSs are listed on the Nasdaq Global Market
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction